The North America Mental Health Screening Market would witness market growth of 11.8% CAGR during the forecast period (2024-2031).
The US market dominated the North America Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $635.7 million by 2031. The Canada market is experiencing a CAGR of 14.3% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 13.3% during (2024 - 2031).
Technological advancements have revolutionized the field of mental health screening, making it more accessible and convenient than ever before. Digital mental health screening tools, including mobile apps and online platforms, have emerged as effective and user-friendly solutions for assessing mental health status.
Moreover, these tools allow individuals to complete screening assessments at their convenience, from the comfort of their homes or on-the-go, without needing an in-person appointment.
The demand for mental health screening tools in North America is on the rise, fueled by alarming statistics that underscore the prevalence and impact of mental health disorders in the region. According to Statistics Canada data from 2022, over 5 million Canadians aged 15 and older, representing 18% of the population, met the diagnostic criteria for a mood, anxiety, or substance use disorder in the previous 12 months.
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others).Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $635.7 million by 2031. The Canada market is experiencing a CAGR of 14.3% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 13.3% during (2024 - 2031).
Technological advancements have revolutionized the field of mental health screening, making it more accessible and convenient than ever before. Digital mental health screening tools, including mobile apps and online platforms, have emerged as effective and user-friendly solutions for assessing mental health status.
Moreover, these tools allow individuals to complete screening assessments at their convenience, from the comfort of their homes or on-the-go, without needing an in-person appointment.
The demand for mental health screening tools in North America is on the rise, fueled by alarming statistics that underscore the prevalence and impact of mental health disorders in the region. According to Statistics Canada data from 2022, over 5 million Canadians aged 15 and older, representing 18% of the population, met the diagnostic criteria for a mood, anxiety, or substance use disorder in the previous 12 months.
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others).Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Market Report Segmentation
By Age Group- Adults (age 19-64 years)
- Children & Adolescents (age 0-18 years)
- Seniors (age 65 and above)
- Clinical Settings
- Educational Institutions & Others
- Workplace/Corporate Programs & Online Platforms
- Telehealth & Virtual Care Solutions
- Self-screening mHealth Apps
- AI-based Screening Tools
- Continuous Monitoring Wearable Devices & Others
- Self-reported Questionnaires & Surveys
- Clinical Interviews
- Observation-based Assessments
- Biomarker Testing
- Physiological Disorders
- Depression & Anxiety
- Eating Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Bipolar Disorder
- Others
- Psychiatric Disorders
- Attention Deficit Hyperactivity Disorder (ADHD)
- Psychotic Disorder
- Dissociative Disorder
- Obsessive Compulsive Disorder
- Schizophrenia
- Others
- Cognitive Disorders
- Cognitive Impairment
- Dementia
- Alzheimer's Disease & Others
- Behavioral Disorders
- Self-Harm
- Aggression
- Sleep Disorder
- Social Withdrawal
- Dissociative Disorder
- Hyperactivity
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Mental Health Screening Market by Age Group
Chapter 6. North America Mental Health Screening Market by Setting
Chapter 7. North America Mental Health Screening Market by Technology
Chapter 8. North America Mental Health Screening Market by Screening Method
Chapter 9. North America Mental Health Screening Market by Application
Chapter 10. North America Mental Health Screening Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Methodology
LOADING...
